Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/11/2024 → 30/04/2025 |
Collaborative partners
- King's College London
- Cardiff University (lead)
- University of Sydney
Funding
- Jazz Pharmaceuticals, plc: £187,263.98
Investigating The Molecular Profile Of Standard-risk Acute Myeloid Leukaemia (AML) In The NCRI AML19 Trial.
- Dillon, Richard (Primary Investigator)
Project: Research